201 related articles for article (PubMed ID: 11400139)
1. A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats.
Cadée JA; Brouwer LA; den Otter W; Hennink WE; van Luyn MJ
J Biomed Mater Res; 2001 Sep; 56(4):600-9. PubMed ID: 11400139
[TBL] [Abstract][Full Text] [Related]
2. In vivo biocompatibility of dextran-based hydrogels.
Cadée JA; van Luyn MJ; Brouwer LA; Plantinga JA; van Wachem PB; de Groot CJ; den Otter W; Hennink WE
J Biomed Mater Res; 2000 Jun; 50(3):397-404. PubMed ID: 10737882
[TBL] [Abstract][Full Text] [Related]
3. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.
Franssen O; Vandervennet L; Roders P; Hennink WE
J Control Release; 1999 Aug; 60(2-3):211-21. PubMed ID: 10425327
[TBL] [Abstract][Full Text] [Related]
4. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
5. In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts.
De Groot CJ; Van Luyn MJ; Van Dijk-Wolthuis WN; Cadée JA; Plantinga JA; Den Otter W; Hennink WE
Biomaterials; 2001 Jun; 22(11):1197-203. PubMed ID: 11336291
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
Kohane DS; Lipp M; Kinney RC; Anthony DC; Louis DN; Lotan N; Langer R
J Biomed Mater Res; 2002 Mar; 59(3):450-9. PubMed ID: 11774302
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic delivery of a macromolecular fluorescent probe by poly(d, l-lactic-co-glycolic acid) microspheres.
Newman KD; Kwon GS; Miller GG; Chlumecky V; Samuel J
J Biomed Mater Res; 2000 Jun; 50(4):591-7. PubMed ID: 10756318
[TBL] [Abstract][Full Text] [Related]
8. Release of recombinant human interleukin-2 from dextran-based hydrogels.
Cadée JA; de Groot CJ; Jiskoot W; den Otter W; Hennink WE
J Control Release; 2002 Jan; 78(1-3):1-13. PubMed ID: 11772444
[TBL] [Abstract][Full Text] [Related]
9. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip.
Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R
J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850
[TBL] [Abstract][Full Text] [Related]
10. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
11. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
Lee JB; Chun KW; Yoon JJ; Park TG
Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
[TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits.
Rong X; Yuan W; Lu Y; Mo X
Int J Nanomedicine; 2014; 9():3057-68. PubMed ID: 25028546
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
14. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of a model protein from enzymatically degrading dextran microspheres.
Franssen O; Stenekes RJ; Hennink WE
J Control Release; 1999 May; 59(2):219-28. PubMed ID: 10332056
[TBL] [Abstract][Full Text] [Related]
16. Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCs.
Rong X; Yang S; Miao H; Guo T; Wang Z; Shi W; Mo X; Yuan W; Jin T
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6025-34. PubMed ID: 22871834
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
[TBL] [Abstract][Full Text] [Related]
18. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.
Horisawa E; Kubota K; Tuboi I; Sato K; Yamamoto H; Takeuchi H; Kawashima Y
Pharm Res; 2002 Feb; 19(2):132-9. PubMed ID: 11883639
[TBL] [Abstract][Full Text] [Related]
19. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.
Fu K; Pack DW; Klibanov AM; Langer R
Pharm Res; 2000 Jan; 17(1):100-6. PubMed ID: 10714616
[TBL] [Abstract][Full Text] [Related]
20. The effect of microsphere degradation rate on the efficacy of polymeric microspheres as bulking agents: an 18-month follow-up study.
Kang SW; Cho ER; Jeon O; Kim BS
J Biomed Mater Res B Appl Biomater; 2007 Jan; 80(1):253-9. PubMed ID: 16850474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
